Gout News

Serum urate testing in older patients with gout does not occur as regularly as it should, based on international recommendations, in those beginning urate lowering therapy, according to data published in Arthritis Care & Research.

Following a major price increase in 2010, the use of colchicine for gout declined while rheumatology and emergency department visits for the disease increased, according to data published in JAMA Internal Medicine.

The adjusted prevalence of gout in Asian Americans doubled from 3.3% in 2011-2012 to 6.6% in 2017-2018, numerically exceeding the prevalence in all other racial and ethnic groups, according to data published in JAMA Network Open.

The presence of glycoprotein acetyl predicts first-time and recurring gout flares beyond serum urate, according to data published in Arthritis & Rheumatology.

Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.

EULAR has initiated a survey that will collect data directly from patients on the impact and outcomes of rheumatic and musculoskeletal diseases, according to a statement released during the EULAR 2023 Congress.

EULAR has launched RheumaFacts, a novel resource for local and national data regarding rheumatic and musculoskeletal diseases in Europe, according to a presenter at the EULAR 2023 Congress.

The Federal Trade Commission has sued to stop Amgen from acquiring Horizon Therapeutics, a potential blockbuster deal that could restrict marketplace competition, according to an FTC press release.

Patients with gout who achieve and maintain target serum urate levels through urate-lowering therapy demonstrate a reduced risk for fractures, according to data published in Arthritis & Rheumatology.

AUSTIN, Texas —Results from a poster presentation here showed that patients with uncontrolled gout treated with the combined therapy of pegloticase and methotrexate saw a reduction in gout symptoms as well as a stable eGFR.